GLP1R and age-related macular degeneration: Notably, a recent large-scale cohort study [40] demonstrated that GLP-1 RAs, including liraglutide, are associated with a significantly reduced risk of both non-exudative and exudative AMD in an aging population, further supporting their translational potential.